Form 8-K MANGOCEUTICALS, INC. For: Jul 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/4/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Mangoceuticals (MGRX) announces termination of Navy Wharf deal
August 4, 2025 9:07 AM EDTAs previously disclosed in that certain Current Report on Form 8-K filed by Mangoceuticals (NASDAQ: MGRX) with the Securities and Exchange Commission (the Commission) on March 25, 2025, on March 24, 2025, we entered into a Master Distribution Agreement (the MSA), with Navy Wharf, Ltd (Navy Wharf). Pursuant to the MSA, the Company was granted the exclusive licensing rights to certain... More
